{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ADHD",
      "Anxiety",
      "Emotional dysregulation",
      "GAD",
      "Treatment response",
      "WRAADDS"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "29152677",
  "DateCompleted": {
    "Year": "2018",
    "Month": "05",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "11",
        "Day": "20"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s11920-017-0859-6"
    ],
    "Journal": {
      "ISSN": "1535-1645",
      "JournalIssue": {
        "Volume": "19",
        "Issue": "12",
        "PubDate": {
          "Year": "2017",
          "Month": "Nov",
          "Day": "20"
        }
      },
      "Title": "Current psychiatry reports",
      "ISOAbbreviation": "Curr Psychiatry Rep"
    },
    "ArticleTitle": "ADHD and Anxiety: Clinical Significance and Treatment Implications.",
    "Pagination": {
      "StartPage": "109",
      "MedlinePgn": "109"
    },
    "Abstract": {
      "AbstractText": [
        "In comparison to the DSM formulation of ADHD, we have proposed that ADHD in adults should be divided into Inattentive and Emotional Dysregulation Presentations. Under both systems, there is potential overlap with generalized anxiety disorder (GAD). We compared data from four distinct populations: ADHD clinical trials, GAD clinical trials, an ADHD clinic, and a forensic clinic. Approximately 25% of patients in each population had comorbid ADHD and anxiety. Comorbid subjects reported more childhood ADHD symptoms and higher scores on ADHD scales and were more likely to fit criteria for ADHD Emotional Dysregulation Presentation or DSM-IV combined type. Comorbid subjects did not drop out at a higher rate and showed significant drug-placebo differences on ADHD symptoms, including Emotional Dysregulation. Conversely, although symptoms of anxiety decreased, there was no drug-placebo difference in improvement."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Psychiatric & Behavioral Solutions, 1522 South 1100 East, Salt Lake City, UT, 84105, USA. fred.reimherr@hsc.utah.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "University of Utah Department of Psychiatry, Salt Lake City, UT, USA. fred.reimherr@hsc.utah.edu."
          }
        ],
        "LastName": "Reimherr",
        "ForeName": "Frederick W",
        "Initials": "FW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Psychiatric & Behavioral Solutions, 1522 South 1100 East, Salt Lake City, UT, 84105, USA."
          }
        ],
        "LastName": "Marchant",
        "ForeName": "Barrie K",
        "Initials": "BK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Rochester School of Medicine, Rochester, NY, USA."
          }
        ],
        "LastName": "Gift",
        "ForeName": "Thomas E",
        "Initials": "TE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Psychiatric & Behavioral Solutions, 1522 South 1100 East, Salt Lake City, UT, 84105, USA."
          }
        ],
        "LastName": "Steans",
        "ForeName": "Tammy A",
        "Initials": "TA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Curr Psychiatry Rep",
    "NlmUniqueID": "100888960",
    "ISSNLinking": "1523-3812"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "epidemiology",
        "psychology",
        "therapy"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Anxiety Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Attention"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Attention Deficit Disorder with Hyperactivity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnostic and Statistical Manual of Mental Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Emotions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    }
  ]
}